Patient Access & Support
How to get your patients started on
Together with your patient, complete the Start Form to prescribe GIVLAARI and initiate verification of benefits and eligibility assessment for financial assistance, if required.
Alnylam Assist™ provides support services for patients prescribed GIVLAARI. Alnylam Assist™ can provide information on coding, coverage, and reimbursement.
Financial Assistance Programs
Alnylam Assist™ offers financial assistance programs for eligible patients. After being prescribed an Alnylam product (GIVLAARI), your patient can talk to an Alnylam Case Manager to learn more. These financial assistance programs may include†:
Commercial Copay Program: Covers certain out-of-pocket costs for eligible patients with commercial insurance‡
Patient Assistance Program (PAP): Provides Alnylam product (GIVLAARI) at no cost to eligible patients, primarily the uninsured, who meet specified financial criteria
*Coverage may vary for individual and plan. Data as of August 2022.
†Patients must meet specified eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue the program at any time.
‡Patients with Medicare, Medicaid, or other government-sponsored insurance are not eligible for the Alnylam Assist™ Commercial Copay Program. Out-of-pocket costs for the administration of Alnylam products will not be covered for patients residing where it is prohibited by law or where otherwise restricted.
Help your patients get started with
GIVLAARI® (givosiran) with Alnylam Assist™
Want to learn more about Alnylam Assist™ and the Start Form?
What happens next:
Alnylam Assist™ provides support services for your patients throughout the treatment process
Alnylam Case Manager
Alnylam Assist™ will connect patients with an Alnylam Case Manager who can provide patient support throughout the GIVLAARI treatment process.
Coverage for GIVLAARI will vary by plan and by patient. Alnylam Assist™ can help determine patient-specific coverage requirements.
Eligible patients* may qualify for financial assistance, which may include the Alnylam Assist™ Patient Assistance Program or Commercial Copay Program.†
Disease and product education
Patient Education Liaisons (PELs) are available to help educate patients, their families, and caregivers on acute hepatic porphyria and GIVLAARI. PELs are employees of Alnylam Pharmaceuticals and do not provide medical advice. All diagnosis and treatment decisions should be made by the treating physician and their patients.
Field Reimbursement Directors (FRDs)
FRDs are experienced professionals who provide education on the coverage and reimbursement process.
*Patients must meet specified eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue the program at any time.
†Patients with Medicare, Medicaid, or other government-sponsored insurance are not eligible for the Alnylam Assist™️ Commercial Copay Program. Out-of-pocket costs for the administration of GIVLAARI will not be covered for patients residing where it is prohibited by law or where otherwise restricted.